Mictonorm (Propiverine Hydrochloride)

Propiverine works by blocking muscarinic (M3) receptors in the bladder’s detrusor muscle, reducing involuntary contractions. It also has calcium‑channel blocking activity, which together increase bladder capacity and lessen urgency and leakage.

The dosage of Mictonorm is individualized. A qualified prescriber determines the appropriate strength, frequency, and duration based on the patient’s age, renal function, and response to therapy.

Safety of propiverine during pregnancy or lactation has not been established. It should be used only if the potential benefit justifies the possible risk to the fetus or infant, and generally it is avoided unless absolutely necessary.

To order Mictonorm, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mictonorm (propiverine) belongs to the antimuscarinic class, similar to oxybutynin and tolterodine. Compared with some alternatives, propiverine may have a lower incidence of dry mouth and offers additional calcium‑channel blocking effects, which can improve bladder relaxation in certain patients.

Mictonorm tablets should be stored at ambient temperature, below 25 °C, in the original blister pack. Keep the product away from moisture, heat and direct sunlight to maintain stability.

Mictonorm is taken orally, usually with a glass of water. The tablet should be swallowed whole and not split or crushed unless specifically instructed by a healthcare professional.

The most serious risks include urinary retention, which may require discontinuation, severe allergic reactions such as anaphylaxis, and angle‑closure glaucoma, a vision‑threatening condition that demands immediate medical attention.

Mictonorm is contraindicated in patients with narrow‑angle glaucoma, severe urinary retention, significant hepatic impairment, or known hypersensitivity to propiverine or any excipients in the formulation.